Multivariate decoding of brain images using ordinal regression☆

Neuroimaging data are increasingly being used to predict potential outcomes or groupings, such as clinical severity, drug dose response, and transitional illness states. In these examples, the variable (target) we want to predict is ordinal in nature. Conventional classification schemes assume that the targets are nominal and hence ignore their ranked nature, whereas parametric and/or non-parametric regression models enforce a metric notion of distance between classes. Here, we propose a novel, alternative multivariate approach that overcomes these limitations — whole brain probabilistic ordinal regression using a Gaussian process framework. We applied this technique to two data sets of pharmacological neuroimaging data from healthy volunteers. The first study was designed to investigate the effect of ketamine on brain activity and its subsequent modulation with two compounds — lamotrigine and risperidone. The second study investigates the effect of scopolamine on cerebral blood flow and its modulation using donepezil. We compared ordinal regression to multi-class classification schemes and metric regression. Considering the modulation of ketamine with lamotrigine, we found that ordinal regression significantly outperformed multi-class classification and metric regression in terms of accuracy and mean absolute error. However, for risperidone ordinal regression significantly outperformed metric regression but performed similarly to multi-class classification both in terms of accuracy and mean absolute error. For the scopolamine data set, ordinal regression was found to outperform both multi-class and metric regression techniques considering the regional cerebral blood flow in the anterior cingulate cortex. Ordinal regression was thus the only method that performed well in all cases. Our results indicate the potential of an ordinal regression approach for neuroimaging data while providing a fully probabilistic framework with elegant approaches for model selection.

[1]  H. Tsukada,et al.  Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys. , 1997, The Journal of pharmacology and experimental therapeutics.

[2]  Nikolaos Koutsouleris,et al.  Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition. , 2013, Schizophrenia bulletin.

[3]  Chandishwar Nath,et al.  Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function , 2012, Psychopharmacology.

[4]  Christian Böhm,et al.  Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease , 2010, NeuroImage.

[5]  Dirk Deleu,et al.  A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. , 2001, Neurology.

[6]  James Clary,et al.  Stochastic theory of minimal realization , 1976, 1976 IEEE Conference on Decision and Control including the 15th Symposium on Adaptive Processes.

[7]  M M Mesulam,et al.  Cholinergic Pathways and the Ascending Reticular Activating System of the Human Brain a , 1995, Annals of the New York Academy of Sciences.

[8]  Karl J. Friston,et al.  Bayesian decoding of brain images , 2008, NeuroImage.

[9]  Andre F. Marquand,et al.  Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers , 2013, NeuroImage.

[10]  M. J. D. Powell,et al.  An efficient method for finding the minimum of a function of several variables without calculating derivatives , 1964, Comput. J..

[11]  Rainer Goebel,et al.  Information-based functional brain mapping. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Thomas G. Dietterich,et al.  Solving Multiclass Learning Problems via Error-Correcting Output Codes , 1994, J. Artif. Intell. Res..

[13]  Paul Maruff,et al.  Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor , 2005, Alzheimer's & Dementia.

[14]  Gwenn S. Smith,et al.  Physostigmine Reversal of Scopolamine-Induced Hypofrontality , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Janaina Mourão Miranda,et al.  Quantitative prediction of subjective pain intensity from whole-brain fMRI data using Gaussian processes , 2010, NeuroImage.

[16]  Shane McKie,et al.  Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. , 2008, Archives of general psychiatry.

[17]  Gwenn S. Smith,et al.  Scopolamine Reduces Frontal Cortex Perfusion , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  Hidenao Fukuyama,et al.  Scopolamine abolishes cerebral blood flow response to somatosensory stimulation in anesthetized cats: PET study , 1994, Brain Research.

[19]  Bertrand Thirion,et al.  Improved Brain Pattern Recovery through Ranking Approaches , 2012, 2012 Second International Workshop on Pattern Recognition in NeuroImaging.

[20]  D. Alsop,et al.  Continuous flow‐driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields , 2008, Magnetic resonance in medicine.

[21]  Karl J. Friston,et al.  The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task , 1995, Experimental Brain Research.

[22]  Manel Martínez-Ramón,et al.  Spatially aggregated multiclass pattern classification in functional MRI using optimally selected functional brain areas. , 2013, Magnetic resonance imaging.

[23]  G. Schwarz Estimating the Dimension of a Model , 1978 .

[24]  S. Williams,et al.  Quantifying the Attenuation of the Ketamine Pharmacological Magnetic Resonance Imaging Response in Humans: A Validation Using Antipsychotic and Glutamatergic Agents , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[25]  M. Kendall A NEW MEASURE OF RANK CORRELATION , 1938 .

[26]  María Pérez-Ortiz,et al.  An Experimental Study of Different Ordinal Regression Methods and Measures , 2012, HAIS.

[27]  Hideo Tsukada,et al.  Muscarinic Receptor Occupancy and Cognitive Impairment: A PET Study with [11C](+)3-MPB and Scopolamine in Conscious Monkeys , 2011, Neuropsychopharmacology.

[28]  R. Murray,et al.  Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study , 2011, Psychological Medicine.

[29]  C. Jack,et al.  Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2005, Alzheimer's & Dementia.

[30]  Wei Chu,et al.  Gaussian Processes for Ordinal Regression , 2005, J. Mach. Learn. Res..

[31]  Bertrand Thirion,et al.  Multiscale Mining of fMRI Data with Hierarchical Structured Sparsity , 2012, SIAM J. Imaging Sci..

[32]  Paolo Fusar-Poli,et al.  At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. , 2013, Schizophrenia bulletin.

[33]  P. McCullagh Regression Models for Ordinal Data , 1980 .

[34]  Janaina Mourão Miranda,et al.  The impact of temporal compression and space selection on SVM analysis of single-subject and multi-subject fMRI data , 2006, NeuroImage.

[35]  Carl E. Rasmussen,et al.  Gaussian processes for machine learning , 2005, Adaptive computation and machine learning.

[36]  Stefan Klöppel,et al.  Multivariate models of inter-subject anatomical variability , 2011, NeuroImage.

[37]  Carl E. Rasmussen,et al.  Gaussian Processes for Machine Learning (GPML) Toolbox , 2010, J. Mach. Learn. Res..

[38]  Janaina Mourão Miranda,et al.  PRoNTo: Pattern Recognition for Neuroimaging Toolbox , 2013, Neuroinformatics.

[39]  Dinggang Shen,et al.  COMPARE: Classification of Morphological Patterns Using Adaptive Regional Elements , 2007, IEEE Transactions on Medical Imaging.

[40]  Carlo Caltagirone,et al.  A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[41]  David Barber,et al.  Bayesian Classification With Gaussian Processes , 1998, IEEE Trans. Pattern Anal. Mach. Intell..

[42]  B. Winblad,et al.  A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD , 2001, Neurology.

[43]  Yong Fan,et al.  Ordinal Ranking for Detecting Mild Cognitive Impairment and Alzheimer's Disease Based on Multimodal Neuroimages and CSF Biomarkers , 2011, MBIA.

[44]  David C. Alsop,et al.  Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: A multi-class pattern recognition approach , 2012, NeuroImage.

[45]  Radford M. Neal Pattern Recognition and Machine Learning , 2007, Technometrics.

[46]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[47]  Makoto Asai,et al.  Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys , 2009, Annals of nuclear medicine.

[48]  J Tauscher,et al.  Significant dissociation of brain and plasma kinetics with antipsychotics , 2002, Molecular Psychiatry.

[49]  M Filippone,et al.  PROBABILISTIC PREDICTION OF NEUROLOGICAL DISORDERS WITH A STATISTICAL ASSESSMENT OF NEUROIMAGING DATA MODALITIES. , 2012, The annals of applied statistics.

[50]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[51]  Paul Pavlidis,et al.  Decoding Unattended Fearful Faces with Whole-Brain Correlations: An Approach to Identify Condition-Dependent Large-Scale Functional Connectivity , 2012, PLoS Comput. Biol..

[52]  Louis Wehenkel,et al.  Decoding Semi-Constrained Brain Activity from fMRI Using Support Vector Machines and Gaussian Processes , 2012, PloS one.

[53]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[54]  Keith Wesnes,et al.  The scopolamine model as a pharmacodynamic marker in early drug development , 2011, Psychopharmacology.

[55]  Douglas Greve,et al.  Functional MRI detection of pharmacologically induced memory impairment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Janaina Mourão Miranda,et al.  Utilizing temporal information in fMRI decoding: Classifier using kernel regression methods , 2011, NeuroImage.

[57]  D. Hassabis,et al.  Decoding Neuronal Ensembles in the Human Hippocampus , 2009, Current Biology.

[58]  Ethem Alpaydin,et al.  Multiple Kernel Learning Algorithms , 2011, J. Mach. Learn. Res..

[59]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.